Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors.
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
Alemtuzumab: The advantages and challenges of a novel therapy in MS.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Alemtuzumab Therapy for Multiple Sclerosis.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Does multiple sclerosis affect glucose tolerance?
A case of septal panniculitis secondary to interferon treatment.
The invisible gorilla strikes again: sustained inattentional blindness in expert observers.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.

Pages